Quick recap: 2011 I saw a doctor form the phone book. I was an airline pilot and one never goes to their FAA AME for any problems less you lose your FAA medical and career. The doctor wanted to do a quick physical because I was a new patient. I saw him because I had a sinus infection that needed antibiotics. He did a DRE and asked when the last PSA I had was. I had never had one so they drew blood and got there results in about 20 minutes. PSA was 68.5. Sent immediately to see a urologist who did another PSA and biopsy. All 12 cores came back as Gleason 5+4y and 7 of the needles were bent, which he had never seen before. Bone scan and CT scan were clear. Had RP and then 2 months pelvic radiation. I was given 18-24 months of life expectancy. I began seeing an oncologist at Tulane who is well regarded and began 6 month Eligard injections and daily sodium bicalutimide. This continued for 2.5 years and I decided to have one more Eligard injection. The PSA began a slow decline over the first year to undetectable and stayed that way until 2018. My oncologist suggested I start taking Androgel for QOL. My testes went on strike and T level even after 3 years off ADT was in the low teens. He thought my QOL was miserable. I hesitated but decided to try it and see what improvement I would see with some testosterone. Unfortunately the T averaged about 120-130 ng/dl every month but the PSA started climbing immediately. Once the PSA reached 3.16 and was doubling every two weeks I ceased the Androgel not telling the oncologist. The improvement in the QOL was not worth killing myself for. The PSA began dropping by 1/2 every other month as the T went back to about 11 ng/dl. I am still castrate sensitive, obviously. I had a FL-18 Scan in Dec of 2021 and there were numerous spots on my spine, left shoulder, ribs, and one large one in my left lung. An Auxin ? scan 10 months prior was clean. The question I have is I am still castrate sensitive and would like to preserve that as long as possible, of course. In the course of reading these forums it seems as though an anti androgen (Enzalutimide, apalutimide, etc) added to ADT is beneficial in a castrate sensitive metastatic patient. Myon oncologist is still recommending staying on Androgel because, and I quote " you are going to die so you might as well have some QOL with the Androgel. I'm reserving judgement of him because he is so well regarded but I can't get any answers from him regarding avenues going forward, what to expect, etc. I didn't fully realize until a visit with my urologist for a bladder cancer clean up that the castration sensitivity ends at some point for every one. I have been riding along thinking I could stay sensitive for years. When the FL-18 scan was gone over with my oncologist I was asking for his thoughts and the only answer I got was " well, they shouldn't be there". It just seems to this layman that an anti androgen might be of additional benefit to me but I was told that that would be only for metastatic patients. Which I am. I remain terribly confused, befuddled, and curious.
Any thoughts would be most appreciated. Tall Allen is the biggest wealth of factual, thorough, and unbiased information and If he would reply as well I would be most relieved.
Sorry for the lengthy diatribe. Just getting nervous and anxious in this endeavor.
Thanks to all.
Alan